| Name |
Atenativ 50 IU/ml prašak i otapalo za otopinu za infuziju |
| Marketing Authorisation Number |
HR-H-577713309 |
| Active Substance |
antitrombin III |
| Composition |
jedna bočica s praškom sadrži 500 IU ili 1000 IU liofiliziranog antitrombina iz ljudske plazme 1 ml otopine za infuziju nakon rekonstitucije s priloženim otapalom (10 ml ili 20 ml vode za injekciju) sadrži 50 IU antitrombina iz ljudske plazme |
| Pharmaceutical Form |
Prašak i otapalo za otopinu za infuziju |
| Manufacturer |
Octapharma AB, Stockholm, Švedska |
| Marketing Authorisation Holder |
Octapharma (IP) SPRL, Route de Lennik 451, Anderlecht, Belgija |
| Marketing Authorisation Date |
17.07.2026 |
| MA Period of Validity |
17.07.2031 |
| Classification Number |
UP/I-530-09/25-01/334 |
| Registration Number |
381-12-01/286-26-12 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
B01AB02 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |